Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Pembrolizumab was approved by the FDA on 13 October 2021. It is used in combination with chemotherapy, with or without bevacizumab, for patients with persistent, recurrent, or metastatic cervical cancer. The tumors must express PD-L1 with a CPS of ≥1, confirmed by an FDA-approved test.
The approved chemotherapy combinations include: